{
    "clinical_study": {
        "@rank": "63919", 
        "acronym": "LIRA-CSV", 
        "arm_group": {
            "arm_group_label": "Liraglutide treated patients", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate transfer of liraglutide from blood to\n      cerebrospinal fluid."
        }, 
        "brief_title": "Liraglutide in Spinal Fluid", 
        "condition": "Liraglutide Blood-brain Transfer", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Type 2 diabetes treated with liraglutide 1.8 mg for 1 month and 5% weight loss\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02104037", 
            "org_study_id": "H-2-2011-027"
        }, 
        "intervention": {
            "arm_group_label": "Liraglutide treated patients", 
            "intervention_name": "Lumbar puncture", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hellerup", 
                    "country": "Denmark", 
                    "zip": "2900"
                }, 
                "name": "Diabetes Research Division, Department of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "official_title": "Liraglutide in Spinal Fluid", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "cerebrospinal fluid concentration of liraglutide", 
            "safety_issue": "No", 
            "time_frame": "time 60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02104037"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Gentofte, Copenhagen", 
            "investigator_full_name": "Mikkel Christensen", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "University Hospital, Gentofte, Copenhagen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mikkel Christensen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}